Low-Dose-Rate Brachytherapy Combined With Ultrahypofractionated Radiation Therapy for Clinically Localized, Intermediate-Risk Prostate Cancer: Results From a Prospective Trial-Reference-Cited by-同舟云学术

Low-Dose-Rate Brachytherapy Combined With Ultrahypofractionated Radiation Therapy for Clinically Localized, Intermediate-Risk Prostate Cancer: Results From a Prospective Trial

Published:2020-11 Issue:4 Volume:108 Page:905-913
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Kollmeier Marisa A.,McBride Sean,Varghese Melissa,Debonis Dylan,Zhang Zhigang,Cohen Gilad,Damato Antonio L.,Mychalczak Borys,Gewanter Richard,Zelefsky Michael J.

Funder

NIH/NCI Cancer Center

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference22 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

2. Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer;Hoskin;Radiother Oncol,2012

3. Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate;Sathya;J Clin Oncol,2005

4. Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer

5. Brachytherapy boost utilization and survival in unfavorable-risk prostate cancer;Johnson;Eur Urol,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate Cancer;Geriatric Medicine;2024

2. Prostate Cancer;Geriatric Medicine;2023

3. Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy boost;Brachytherapy;2022-09

4. Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost;Radiation Oncology;2022-01-20

5. Control charts for evaluation of quality of low-dose-rate brachytherapy for prostate cancer;Journal of Contemporary Brachytherapy;2022